Principal Scientist
BioMarin Pharmaceutical Inc
Novato, California, United States
Brian Long is a Principal Scientist in Translational Sciences and Clinical Immunology at BioMarin Pharmaceutical, a biotechnology company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. Brian provides immunologic expertise to drug programs across developmental stages and develops immunogenicity and safety strategies for novel biologic therapeutics, most recently focusing on AAV mediated gene therapies. Brian received his Ph.D. in Microbiology and Immunology from The University of North Carolina, Chapel Hill and pursued post-doctoral training at The Gladstone Institutes of Virology and Immunology, and the University of California, San Francisco where he investigated the role of innate immunity in HIV disease pathogenesis. Following his post-doctoral training, he continued as a Research Scientist in the Division of Experimental Medicine at UCSF where he worked on the development and standardization of humanized mouse models for the evaluation of HIV immunology, therapeutics and drug discovery. Brian joined BioMarin in June of 2014 and has over 25 years of experience in immunology and infectious disease, autoimmunity, cell signaling, cancer biology and drug development.
Sunday, June 25, 2023
17:20 – 17:30 ET